Results 31 to 40 of about 59,669 (311)
Indian Journal of Endocrinology and Metabolism, 2022 Background and Aims: No study to date has assessed the effect of hydroxychloroquine on various parameters of glycaemic variability. To assess the effect of hydroxychloroquine on glycaemic variability in type 2 diabetes patients uncontrolled on ...
Rajesh Rajput +3 more
doaj +1 more source
First Principle Simulation of Coated Hydroxychloroquine on Ag, Au and Pt Nanoparticle as a Potential Candidate for Treatment of SARS-CoV-2 (COVID-19) [PDF]
, 2020 The {\it{in vitro}} antiviral activity of Hydroxychloroquine (HCQ) and chloroquine (CQ) against SARS-CoV-2 from the first month of pandemic proposed these drugs as the appropriate therapeutic candidate, although their side effect directed the clinical test toward optimizing the safe utilization strategies.
arxiv +1 more source
Trials, 2020 Objectives Primary objective To determine whether chemoprophylaxis with hydroxychloroquine versus placebo increases time to contracting coronavirus disease 2019 (COVID-19) in frontline healthcare workers.
Carmel M. McEniery +8 more
doaj +1 more source
Temporal and geographic analysis of the Hydroxychloroquine controversy in the French Twittosphere [PDF]
arXiv, 2023 At the beginning of the COVID-19 pandemic, the urge to find a cure triggered an international race to repurpose known drugs. Chloroquine, and next Hydroxychloroquine, emerged quickly as a promising treatment. While later clinical studies demonstrated its inefficacy and possible dangerous side effects, the drug caused heated and politicized debates at ...
arxiv
Role of body mass index in outcomes of patients hospitalized with COVID‐19 illness
Obesity Science &Practice, Volume 8, Issue 6, Page 748-756, December 2022., 2022 Abstract Background Since the start of coronavirus disease 2019 (COVID‐19) pandemic, several studies have linked obesity with severity of illness as well as mortality in patients with COVID‐19. Outcomes of patients with overweight or obesity, who develop critical illness, have been studied extensively over the past decade where the studies have shown ...
Maleeha Zahid +8 more
wiley +1 more source
Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
Pharmaceutics, 2020 (1) Background: Hydroxychloroquine is used to treat malaria and autoimmune diseases, and its potential use against COVID-19 is currently under investigation.
Johanna Weiss +2 more
doaj +1 more source
Journal of Prescribing Practice, 2020 In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #hydroxychloroquine
openaire +3 more sources
Frontiers in Pharmacology, 2019 The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention ...
Xin Qiao +10 more
doaj +1 more source
The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
Frontiers in Pharmacology, 2020 The emergence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) in China, reported to the World Health Organization on December 31, 2019, has led to a large global pandemic and is a major public health issue.
Tyler C. Beck +7 more
doaj +1 more source
The place of hydroxychloroquine in modern dermatology
Przegląd Dermatologiczny, 2021 Hydroxychloroquine has been known since the 1940s. It was initially used to treat malaria. Currently, it has a well-established position in the treatment of lupus erythematosus. The knowledge about its benefits is increasing over time.
Aleksandra Dańczak-Pazdrowska +1 more
doaj +1 more source